onr:"swepub:oai:lup.lub.lu.se:999097eb-429c-4cc6-91dc-50dbab0f740d"
Search: onr:"swepub:oai:lup.lub.lu.se:999097eb-429c-4cc6-91dc-50dbab0f740d" > EANM Dosimetry Comm...
- 1 of 1
- Previous record
- Next record
- To hitlist
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry
- Hindorf, Cecilia (author)
- Glatting, Gerhard (author)
- Chiesa, Carlo (author)
- show more...
- Flux, Glenn (author)
- show less...
- (creator_code:org_t)
- 2010-04-22
- 2010
- English.
- In: European Journal of Nuclear Medicine and Molecular Imaging. - : Springer Science and Business Media LLC. - 1619-7070 .- 1619-7089. ; 37:6, s. 1238-1250
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The level of administered activity in radionuclide therapy is often limited by haematological toxicity resulting from the absorbed dose delivered to the bone marrow. The purpose of these EANM guidelines is to provide advice to scientists and clinicians on data acquisition and data analysis related to bone-marrow and whole-body dosimetry. The guidelines are divided into sections "Data acquisition" and "Data analysis". The Data acquisition section provides advice on the measurements required for accurate dosimetry including blood samples, quantitative imaging and/or whole-body measurements with a single probe. Issues specific to given radiopharmaceuticals are considered. The Data analysis section provides advice on the calculation of absorbed doses to the whole body and the bone marrow. The total absorbed dose to the bone marrow consists of contributions from activity in the bone marrow itself (self-absorbed dose) and the cross-absorbed dose to the bone marrow from activity in bone, larger organs and the remainder of the body. As radionuclide therapy enters an era where patient-specific dosimetry is used to guide treatments, accurate bone-marrow and whole-body dosimetry will become an essential element of treatment planning. We hope that these guidelines will provide a basis for the optimization and standardization of the treatment of cancer with radiopharmaceuticals, which will facilitate single- and multi-centre radionuclide therapy studies.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
Keyword
- Internal dosimetry
- Radionuclide therapy
- Bone marrow
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
- European Journal of Nuclear Medicine and Molecular Imaging (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hindorf, Cecilia
- Glatting, Gerhar ...
- Chiesa, Carlo
- Lindén, Ola
- Flux, Glenn
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Radiology Nuclea ...
- Articles in the publication
- European Journal ...
- By the university
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
